Astria Therapeutics, Inc. Long-Term Debt, Maturity, Year Four

Astria Therapeutics, Inc. Long-Term Debt, Maturity, Year Four

Astria Therapeutics, Inc. had Long-Term Debt, Maturity, Year Four of $2.50 million as of 2015-09-30, per its 10-Q filed 2015-11-12.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2015-11-12

• 2015-09-30: Long-Term Debt, Maturity, Year Four $2.50M.
• 2015-06-30: Long-Term Debt, Maturity, Year Four $2.50M.
• 2014-12-31: Long-Term Debt, Maturity, Year Four $1.25M.